Literature DB >> 24759148

Developing individualized coagulation profiling of disease risk: thrombin generation dynamic models of the pro and anticoagulant balance.

Kathleen E Brummel-Ziedins1.   

Abstract

Global assays and computational models have advanced research into the realm of individualized profiling of hemostatic states. This brief review will describe one computational approach which utilizes an integrated method that evaluates the dynamics of thrombin generation by defining interactions of the pro and anticoagulant proteins, enzymes and cofactors based upon individualized concentrations of select factors. This plasma composition based computational modeling can provide a mechanism based bridge between empirical global assays of coagulation and individualized risk prediction.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759148     DOI: 10.1016/j.thromres.2014.03.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  Computationally Driven Discovery in Coagulation.

Authors:  Kathryn G Link; Michael T Stobb; Dougald M Monroe; Aaron L Fogelson; Keith B Neeves; Suzanne S Sindi; Karin Leiderman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

2.  In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus.

Authors:  Kathleen E Brummel-Ziedins; Matthew Gissel; Jacqueline Neuhaus; Álvaro H Borges; David R Chadwick; Sean Emery; James D Neaton; Russell P Tracy; Jason V Baker
Journal:  Res Pract Thromb Haemost       Date:  2018-09-11

Review 3.  Thrombin generation assays are versatile tools in blood coagulation analysis: A review of technical features, and applications from research to laboratory routine.

Authors:  François Depasse; Nikolaus B Binder; Julia Mueller; Thomas Wissel; Stephan Schwers; Matthias Germer; Björn Hermes; Peter L Turecek
Journal:  J Thromb Haemost       Date:  2021-09-26       Impact factor: 16.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.